## Abstract Eliminating Epstein‐Barr virus (EBV) genomes from infected cells is an intriguing theoretical strategy in therapy for EBV‐associated malignant diseases. Respective patterns were characterized for hydroxyurea (HU)‐promoted loss of EBV genomes from EBV‐infected epithelioid cell lines deri
Localization polymorphism of EBV DNA genomes in the chromosomes of Burkitt lymphoma cell lines
✍ Scribed by M. -C. Trescol-Biémont; C. Biémont; J. Daillie
- Publisher
- Springer
- Year
- 1987
- Tongue
- English
- Weight
- 733 KB
- Volume
- 95
- Category
- Article
- ISSN
- 0009-5915
No coin nor oath required. For personal study only.
✦ Synopsis
The localization of Epstein-Barr virus (EBV) genomes in nuclei of the human lymphoblastoid cell lines Raji, Jijoye, P3HR-1, Daudi and Ramos was investigated by in situ hybridization with biotinylated EBV DNA probes. We found that all sites of hybridization were associated with the chromosomes. Only some of these sites were present on both chromatids and these had a non-random distribution; these sites could represent EBV sequences integrated at specific points on the chromosomes. The total mean site number corresponded with the number of viral DNA copies estimated in the different cell lines by other techniques, but the copy number was highly variable from cell to cell in a given line.
📜 SIMILAR VOLUMES
The Epstein-Barr virus genome contained in the Burkitt lymphoma line Namalwa was previously localized to the short arm of chromosome I. Analysis of a different subline of the same Namalwa line by means of Southern analysis carried out on genomic D N A , as well as in situ hybridization, showed a loc
## Abstract Using a high‐resolution chromosome banding technique, which provided more elongated and distinctly banded chromosomes, some new evidence was obtained for localization of break points in Burkitt lymphoma marker chromosomes. As a result, the characteristic translocation between chromosome
## Abstract The molecular biological characteristics of Burkitt lymphoma (BL), in addition to the presence of the Epstein‐Barr virus (EBV) in some forms, relies on well‐characterized alterations, such as __MYC__ translocations and __TP53__ inactivations. To ascertain the number and location of othe
## Abstract Hydroxyurea (HU), as an inhibitor of ribonucleotide reductase (RR) through interaction with the R2 component, has been used in the treatment of malignancies. Recently, therapeutic strategies in Epstein‐Barr Virus (EBV)‐targeted lymphoma have been reported. In order to study the effect o
## Abstract The effect of two DNA antagonists (IUDR and Ara C) on EBV‐associated antigens was studied in two BL‐derived carrier culture lines (P3HR‐1 and Onesmas). Both drugs led to an accumulation of the early antigen (EA) from 2% in the untreated to 5–40% in the treated cultures. Ara C blocked th